ELEVANCE HEALTH, INC., 424B3 filed on 9/9/2025
Prospectus filed pursuant to Rule 424(b)(3)
v3.25.2
Submission
Sep. 09, 2025
Submission [Line Items]  
Central Index Key 0001156039
Registrant Name Elevance Health, Inc.
Registration File Number 333-275251
Form Type S-3
Submission Type 424B3
Fee Exhibit Type EX-FILING FEES
Offering Table N/A
Offset Table N/A N/A
Combined Prospectus Table N/A N/A
v3.25.2
Offerings
Sep. 09, 2025
USD ($)
shares
Offering: 1  
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Debt
Security Class Title 4.000% Notes due 2028
Amount Registered | shares 750,000,000
Maximum Aggregate Offering Price $ 749,602,500.00
Fee Rate 0.01531%
Amount of Registration Fee $ 114,764.14
Offering Note The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
Offering: 2  
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Debt
Security Class Title 4.600% Notes due 2032
Amount Registered | shares 750,000,000
Maximum Aggregate Offering Price $ 748,665,000.00
Fee Rate 0.01531%
Amount of Registration Fee $ 114,620.61
Offering Note See Offering Note 1.
Offering: 3  
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Debt
Security Class Title 5.000% Notes due 2036
Amount Registered | shares 1,000,000,000
Maximum Aggregate Offering Price $ 996,400,000.00
Fee Rate 0.01531%
Amount of Registration Fee $ 152,548.84
Offering Note See Offering Note 1.
Offering: 4  
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Debt
Security Class Title 5.700% Notes due 2055
Amount Registered | shares 500,000,000
Maximum Aggregate Offering Price $ 497,155,000.00
Fee Rate 0.01531%
Amount of Registration Fee $ 76,114.43
Offering Note See Offering Note 1.
v3.25.2
Fees Summary
Sep. 09, 2025
USD ($)
Fees Summary [Line Items]  
Total Offering $ 2,991,822,500.00
Previously Paid Amount 0.00
Total Fee Amount 458,048.02
Total Offset Amount 0.00
Net Fee 458,048.02
Narrative - Max Aggregate Offering Price $ 2,991,822,500.00
Final Prospectus true